文献速递冠心病心力衰竭与心肌病心律失常

慢性肾脏病中的心血管疾病

Cardiovascular disease in chronic kidney disease.
PubMed 文献 · Eur Heart J · 2025-01-01

本文为综述,阐述慢性肾脏病(CKD)患者发生心血管疾病(CVD)风险增加,涉及冠心病、卒中、心力衰竭、心律失常及心源性猝死。文章讨论CVD与CKD并存的病理生理机制(共同危险因素如糖尿病和高血压,以及炎症、贫血、容量负荷过重和尿毒症毒素),强调识别CKD对CVD风险预测的重要性,并提倡心脏科与肾内科等多学科协作管理。

要点

  • CKD患者CVD风险增加,可表现为冠心病、卒中、心衰、心律失常及心源性猝死。
  • CVD与CKD并存显著影响患者预后,需重视风险评估。
  • 管理CKD患者CVD风险需心脏科、肾内科等多学科协作。

核心结论

  • CKD患者CVD风险增加,二者并存显著影响预后,需多学科协作管理。

研究设计与样本

  • 本文为State-of-the-Art综述,未报告系统检索范围与样本量。

主要发现

  • CKD患者CVD可表现为冠心病、卒中、心力衰竭、心律失常和心源性猝死。
  • CVD与CKD并存对患者预后有重大影响。
  • 病理生理机制涉及共同危险因素(如糖尿病和高血压)以及炎症、贫血、容量负荷过重和尿毒症毒素。

临床怎么用

  • 识别和刻画CKD对CVD风险预测至关重要。
  • 降低CKD患者CVD风险需心脏科、肾内科及其他卫生保健专业人员参与的多学科方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Individuals with chronic kidney disease (CKD) exhibit an increased risk for the development of cardiovascular disease (CVD) with its manifestations coronary artery disease, stroke, heart failure, arrhythmias, and sudden cardiac death. The presence of both, CVD and CKD has a major impact on the prognosis of patients. This association likely reflects the involvement of several pathophysiological mechanisms, including shared risk factors (e.g. diabetes and hypertension), as well as other factors such as inflammation, anaemia, volume overload, and the presence of uraemic toxins. Identifying and characterizing CKD is crucial for appropriate CVD risk prediction. Mitigating CVD risk in patients with CKD mandates a multidisciplinary approach involving cardiologists, nephrologists, and other health care professionals. The present State-of-the-Art Review addresses the current understanding on the pathophysiological link between CVD and CKD, clinical implications and challenges in the treatment of these patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Marx-Schütt K, Cherney DZI, Jankowski J, et al. Cardiovascular disease in chronic kidney disease. Eur Heart J. 2025. PMID: 40196891. doi:10.1093/eurheartj/ehaf167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。